These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population. Perkins JG; Flynn JM; Howard RS; Byrd JC Cancer; 2002 Apr; 94(7):2033-9. PubMed ID: 11932906 [TBL] [Abstract][Full Text] [Related]
5. Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis. Morrison VA Clin Lymphoma Myeloma; 2009 Oct; 9(5):365-70. PubMed ID: 19858055 [TBL] [Abstract][Full Text] [Related]
6. Update on prophylaxis and therapy of infection in patients with chronic lymphocytic leukemia. Morrison VA Expert Rev Anticancer Ther; 2001 Jun; 1(1):84-90. PubMed ID: 12113137 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immune globulin in chronic lymphocytic leukaemia. Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic strategies to meet infectious complications in fludarabine-treated CLL. Südhoff T; Arning M; Schneider W Leukemia; 1997 Apr; 11 Suppl 2():S38-41. PubMed ID: 9178837 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in the treatment of chronic lymphocytic leukemia: defining the role of intravenous immunoglobulin. Besa EC Semin Hematol; 1992 Jul; 29(3 Suppl 2):14-23. PubMed ID: 1380736 [No Abstract] [Full Text] [Related]
10. Infection and immunity in chronic lymphocytic leukemia. Tsiodras S; Samonis G; Keating MJ; Kontoyiannis DP Mayo Clin Proc; 2000 Oct; 75(10):1039-54. PubMed ID: 11040852 [TBL] [Abstract][Full Text] [Related]
11. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia. Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052 [TBL] [Abstract][Full Text] [Related]
12. Management of infectious complications in patients with chronic lymphocytic leukemia. Morrison VA Hematology Am Soc Hematol Educ Program; 2007; ():332-8. PubMed ID: 18024648 [TBL] [Abstract][Full Text] [Related]
13. Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy. Marotta G; Bigazzi C; Lenoci M; Tozzi M; Bocchia M; Lauria F Haematologica; 2000 Dec; 85(12):1268-70. PubMed ID: 11114133 [TBL] [Abstract][Full Text] [Related]
14. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia. Kay NE Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115 [TBL] [Abstract][Full Text] [Related]
15. Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia. Awais A; Tam CS; Kontoyiannis D; Ferrajoli A; Duvic M; Cortes J; Keating MJ Clin Infect Dis; 2008 Apr; 46(7):e69-71. PubMed ID: 18444808 [TBL] [Abstract][Full Text] [Related]
16. A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia. Weiss MA Semin Oncol; 2000 Apr; 27(2 Suppl 5):41-3. PubMed ID: 10877051 [TBL] [Abstract][Full Text] [Related]
17. Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate. Castelli R; Vismara A; Pavia G; Dagani R; Porro T Ann Ital Med Int; 2002; 17(1):47-50. PubMed ID: 11975114 [TBL] [Abstract][Full Text] [Related]
18. High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy. Dungarwalla M; Evans SO; Riley U; Catovsky D; Dearden CE; Matutes E Haematologica; 2008 Mar; 93(3):475-6. PubMed ID: 18310545 [TBL] [Abstract][Full Text] [Related]
19. Symposium on infections in the compromised host. The leukemias. Newman KA Nurs Clin North Am; 1985 Mar; 20(1):227-34. PubMed ID: 3919366 [TBL] [Abstract][Full Text] [Related]
20. Nursing guidelines for managing infections in patients with chronic lymphocytic leukemia. Moran M; Browning M; Buckby E Clin J Oncol Nurs; 2007 Dec; 11(6):914-24. PubMed ID: 18063549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]